TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07650227: Multicenter, Double Blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Bronchitis in Adult Patients

Sponsor: Materia Medica Holding · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 308 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$11,125,984

Rescue Site Savings

+$7,354,464

Unlock Full NCT07650227 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07650227 Rescue Dossier →